Journals / İzmir Tepecik Eğitim Hastanesi Dergisi / 2020 / Cilt: 30 - Sayı: 0

COVID-19 Transmission and Prevention

COVID-19 Bulaş Yolları ve Önleme

Pages
36–42
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Preventive strategies focus on careful infection control, including patient isolation and appropriate measures to be taken during diagnosis and clinical care for an infected patient.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The epidemic caused by the SARS-CoV-2 virus and the disease identified as COVID-19 infection, which emerged in December 2019 in China, was declared as a global pandemic by the World Health Organization in March 2020.
📊
Key Findings & Data:There is currently no treatment that is fully effective on COVID-19 or its protective vaccine is not available.
💡
Conclusion & Impact:Preventive strategies focus on careful infection control, including patient isolation and appropriate measures to be taken during diagnosis and clinical care for an infected patient.
🔬Design:Research Article
📍Scope:2019 Verileri
⚙️Variables:Domain Parameters

Abstract

The epidemic caused by the SARS-CoV-2 virus and the disease identified as COVID-19 infection, which emerged in December 2019 in China, was declared as a global pandemic by the World Health Organization in March 2020. The source of the outbreak has not been clearly explained. It is estimated that the virus mutated on animals and acquired the characteristic feature of human-to-human transmission. The distribution and outcomes of the epidemic in different regions change according to many factors such as climate, hygiene, population, demographic characteristics, health facilities, and transmission characteristics. The disease is transmitted mainly through droplets and contact. Other routes of transmisision as inhalation of aerosols, are also shown. The risk of transmission of infection varies depending on the type and duration of exposure, the use of preventive measures and possible individual factors. There is currently no treatment that is fully effective on COVID-19 or its protective vaccine is not available. However, studies on treatment and vaccines are ongoing. The most important measures to prevent the spread of the virus in society are hand hygiene, social distance and quarantine. Early screening, diagnosis, isolation and treatment are necessary to prevent further spread. Preventive strategies focus on careful infection control, including patient isolation and appropriate measures to be taken during diagnosis and clinical care for an infected patient.

Özet

Çin’de 2019 aralık ayında başlayan SARS-CoV-2 virüsünün ve COVID-19 olarak tanımlanan hastalığın neden olduğu salgın, Dünya Sağlık Örgütü tarafından 2020 Mart ayında küresel pandemi olarak ilan edilmiştir. Salgının kaynağı net olarak açıklanamamıştır. Virüsün hayvanlar üzerinde mutasyona uğrayarak insandan insana bulaşma özelliği kazandığı düşünülmektedir. Salgının farklı bölgelerde dağılımı ve sonuçları, iklim, hijyen, nüfus, demografik özellikler, bulaş özellikleri gibi birçok faktöre göre farklılık göstermektedir. Hastalık esas olarak damlacık ve temas yoluyla bulaşmaktadır. Ayrıca aerosolların solunması gibi başka yollar da gösterilmiştir. Enfeksiyonun bulaşma riski, maruziyet türü ve süresine, önleyici önlemlerin kullanımına ve olası bireysel faktörlere göre değişir. Henüz COVID-19’a tamamen etkili olan bir tedavi ya da koruyucu bir aşı yoktur, ancak tedavi ve aşılarla ilgili çalışmalar devam etmektedir. Virüsün toplum içinde yayılmasını engelleyecek en önemli önlemler el hijyeni, sosyal mesafe ve karantinadır. Daha fazla yayılmayı engellemek için erken tarama, tanı, izolasyon ve tedavi gereklidir. Önleyici stratejiler, hastaların izolasyonu ve enfekte bir hastaya teşhis ve klinik bakım sağlanması sırasında alınması gereken uygun önlemler dahil olmak üzere dikkatli enfeksiyon kontrolüne odaklanır.

🔖

Cite This Article

TÜRKEN, M., KÖSE, Ş. (2020). COVID-19 Transmission and Prevention. İzmir Tepecik Eğitim Hastanesi Dergisi, Cilt: 30 - Sayı: 0, 36–42. https://ajindex.com/articles/178274

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Çetin C, Kara A. Global surveillance, travel, and trade during a pandemic. Turk J Med Sci. 2020
  2. [CrossRef] 2. World Health Organization. WHO announces COVID-19 outbreak a pandemic. 2020. Available from: http://www. euro.who.int/en/health-topics/health-emergencies/ coronavirus-covid-19/news/news/2020/3/who-announcescovid-19-outbreak-a-pandemic Accessed: 6 May 2020 3. Zhang T, Wu Q, Zhang Z. Probable Pangolin Origin of SARSCoV-2 Associated with the COVID-19 Outbreak. Curr Biol. 2020
  3. 30(7):1346-51. [CrossRef] 4. Lv L, Li G, Chen J, Liang X, Li Y. Comparative genomic analysis revealed specific mutation pattern between human coronavirus SARS-CoV-2 and Bat-SARSr-CoV RaTG13. bioRxiv. 2020. [CrossRef] 5. Genomic epidemiology of novel coronavirus - Global subsampling. 2019-2020 Available from: https://nextstrain.org/ ncov/global Accessed: 6 May 2020. 6. Petersen E, Gökengin D. SARS-CoV-2 epidemiology and control, different scenarios for Turkey. Turk J Med Sci. 2020
  4. [CrossRef] 7. Wang FS, Zhang C. What to do next to control the 2019-nCoV epidemic? The Lancet. 2020
  5. 395(10222):391-3. [CrossRef] 8. To KKW, Tsang OTY, Leung WS, et al. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. Lancet Infect Dis. 2020
  6. 20(5):565- 74. [CrossRef] 9. Cheng PKC, Wong DA, Tong LKL, et al. Viral shedding patterns of coronavirus in patients with probable severe acute respiratory syndrome. The Lancet. 2004
  7. 363(9422):1699-1700. [CrossRef] 10. Pan Y, Zhang D, Yang P, et al. Viral load of SARS-CoV-2 in clinical samples. Lancet Infect Dis. 2020
  8. 20(4):411-2. [CrossRef] 11. Liu Y, Yan LM, Wan L, et al. Viral Dynamics in mild and severe cases of COVID-19. Lancet Infect Dis. 2020. [CrossRef] 12. Walls AC, Park YJ, Tortorici MA, Wall A, McGuire AT, Veesler D. Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein. Cell. 2020
  9. 181(2):281-92. [CrossRef] 13. World Health Organization Department of Communicable Disease Surveillance and Response. Consensus document on the epidemiology of severe acute respiratory syndrome (SARS) [online]. 2003 Available from: https://www.who.int/ csr/sars/WHOconsensus.pdf Accessed: 6 May 2020. 14. Akın L, Gözel MG. Understanding dynamics of pandemics. Turk J Med Sci. 2020
  10. [CrossRef] 15. Sanche S, Lin YT, Xu C, Romero-Severson E, Hengartner N, and Ruian K. High Contagiousness and Rapid Spread of Severe A